Since 1995, the Northwest Clinical Research Center has partnered with the pharmaceutical industry to conduct clinical research trials and is dedicated to providing quality medical treatment and patient safety. Each patient receives psychological assessments and health evaluations by our medical staff. Our specialty is psychiatry and the treatment of mood disorders. Dr. Khan and his staff also have over 20 years of experience with child and adolescent depression, bipolar and schizophrenia.
ARIF KHAN, M.D.
Arif Khan, MD, is a Board Certified Psychiatrist and Adjunct Professor of Psychiatry at Duke University School of Medicine and has treated many patients diagnosed with Autism Spectrum Disorder. He is the Medical Director and Principal Investigator at Northwest Clinical Research Center in Bellevue, Washington. Dr. Khan has been conducting clinical trials in the greater Seattle area since 1984 and founded NWCRC in 1995.
Dr. Khan as conducted over 90 clinical trials studying depression, bipolar, and schizophrenia. His research has been instrumental in the FDA approval of medication such as Cymbalta®, Paroxetine, Citalopram, Duloxetine and Vilazodone, just to name a few.
Click HERE to for Dr. Khan’s Cirriculum Vitae
Click HERE for a list of Dr. Khan’s online publications
GAYLON KIPP, M.D.
Dr. Kipp is a Board Certified primary care physician and has provided care to patients for over 30 years. He is currently a medical sub-investigator and has contributed to over 65 clinical trials here at NWCRC. When asked about his work, he says, “I enjoy patient contact and knowing that I’m making a difference through research.”